Skip to contentO
Oragenics Inc
O
OGENOragenics Inc Q1 2025 · 10-Q
Revenue—
Net Income-$2.22M-$2.22MN/M vs Q1 2024 EPS Diluted-$3.65-$3.65N/M vs Q1 2024 Operating Income-$2,026,227N/M Operating Cash Flow-$2,112,090N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oragenics Inc · CIK 1174940 · Engraved from SEC EDGAR
ended Mar 31, 2025 · filed May 9, 2025 · 39 d after period end